CAS 335161-27-8

[1-(5-Fluoropentyl)-6-nitro-1H-indol-3-yl]-1-naphthalenylmethanone

Formula: C₂₄H₂₁FN₂O₃

InChI: InChI=1S/C24H21FN2O3/c25-13-4-1-5-14-26-16-22(20-12-11-18(27(29)30)15-23(20)26)24(28)21-10-6-8-17-7-2-3-9-19(17)21/h2-3,6-12,15-16H,1,4-5,13-14H2

InChI key: InChIKey=LNGVQORPSNNMSZ-UHFFFAOYSA-N

SMILES: C(=O)(C=1C=2C(N(CCCCCF)C1)=CC(N(=O)=O)=CC2)C=3C4=C(C=CC3)C=CC=C4

Synonyms:

• Methanone, [1-(5-fluoropentyl)-6-nitro-1H-indol-3-yl]-1-naphthalenyl-
• [1-(5-Fluoropentyl)-6-nitroindol-3-yl]-naphthalen-1-ylmethanone
• [1-(5-Fluoropentyl)-6-nitro-1H-indol-3-yl]-1-naphthalenylmethanone

AM 1235

Controlled Product

CAS: 335161-27-8

Formula: C₂₄H₂₁FN₂O₃

Color and Shape: Neat

Molecular weight: 404.434

Ref: TR-A575885

AM-1235

CAS: 335161-27-8

AM-1235 is a potent and selective cannabinoid receptor CB1 agonist.

Formula: C₂₄H₂₁FN₂O₃

Purity: 99.92%

Color and Shape: Yellow Solid

Molecular weight: 404.43

Ref: TM-T29930

AM 1235

Controlled Product

CAS: 335161-27-8

AM 1235 is a synthetic cannabinoid with cannabimimetic properties. It has affinity for the CB2 receptor, which is found in host plants, bryophytes, and animals. AM 1235 has been shown to inhibit the frequency of re-epithelialisation in an animal model of glaucoma. This drug also binds to the plasma concentration of medications such as buprenorphine and ketamine. AM 1235 inhibits the activity of acetylcholinesterase enzymes by acting on their active site, preventing them from breaking down acetylcholine. This leads to increased levels of acetylcholine in synapses and causes a variety of effects such as memory impairment and convulsions.

Purity: Min. 95%

Ref: 3D-CA175165